ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA

Detalhes bibliográficos
Autor(a) principal: Pohl, Ariane Ribas
Data de Publicação: 2023
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional Universidade Franciscana
Texto Completo: http://www.tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/1197
Resumo: Melanoma is the most aggressive form of skin cancer, being a highly malignant neoplasm that affects melanocytes, representing less than 5% of all cases of skin cancer, however, it causes the vast majority of deaths, reaching 80%. Overall, historically survival has been low for patients with metastatic disease and response to conventional chemotherapy has been infrequent. Due to the large number of people affected, the severity and mortality of this disease, innovative methods such as nanostructures with plant compounds may become an alternative for the treatment of cancer. Among the bioactives, quercetin and curcumin stand out, with high antioxidant and anti inflammatory power, and capsaicin, which favors the uptake of curcumin after oral ingestion. However, these natural actives have low aqueous solubility, a characteristic that makes it difficult to use them in clinical trials, and low oral bioavailability, indicating a low use of bioactives. To overcome these problems, incorporating bioactives into solid lipid nanoparticles (NLS) or nanostructured lipid composites (CLN) may allow for more efficient delivery. In this context, the objective of this study is to evaluate the effect of both, the solid lipid nanoparticle containing curcumin and capsaicin (NCC), and the nanostructured lipid carrier containing quercetin (NQ) in B16-F10 melanoma cells, in in vitro and in vitro assays. alive. The cytotoxic potentials of the nanoformulations were determined by the MTT, LDH, Neutral Red, Crystal Violet, Picogreen and hemolysis tests. All concentrations of NCC and NQ reduced melanoma cell viability by the MTT, Neutral Red, and Crystal Violet test. There was greater binding to DNA in the NCC group in the Picogreen test, showing DNA extravasation from the intracellular to the extracellular environment visualized by the double-stranded intercalator. There was a dose-dependent increase in cell death for both nanostructures in the LDH test. There was a reduction in DCFH oxidation, an indication that the antioxidant power of NCC and NQ reduced reactive oxygen species in these groups when compared to the control group. The nanoformulations did not cause hemolysis. Curcumin exhibited concentration-dependent anticoagulant activity, and the NBC and NQ groups did not affect the extrinsic coagulation cascade. For NCC and NBQ they were higher than the accepted range, showing that the anticoagulant action of curcumin in prolonging the clotting time may be due to the hydrophobic groups of its structure. In in vivo tests, treatments with NCC and NQ nanostructures significantly decreased the tumor growth rate over the 21 days of the experiment, and tumor volume was significantly inhibited by approximately 76% (0.23 mm3) and 68 % (0.3 mm3) after treatment with NCC and NQ, respectively, and tumor weight was significantly inhibited from 58% (0.71 g) and 32% (1.15 g) in NCC and NQ groups, respectively, when compared to the melanoma group (1.68 g). In the cytokine test, there was a reduction in IL-17 values in the NQ and NCC groups compared to the melanoma group, indicating the possibility of decreased tumor growth, and a decrease in IL-6 values in the group treated with NQ and NCC, decreasing thus the proliferation of tumor cells. For TNF-α, there was a reduction in the melanoma group and an increase in the NQ and NCC groups, suggesting induction of apoptosis and necrosis of tumor cells. The reduction in IL-10 values corroborates the histology results that did not find signs of metastasis in the lung. Reduction in IL-2 in the NQ and NCC groups, indicating a reduction in the proliferation of cancer cells. The results obtained in the hemogram corroborate what was found in the histology, and in the histology test, where there was no metastasis to the lung. These previous results demonstrate the ability of NCC and NQ to reduce B16-F10 melanoma cells. This thesis is original and innovative, because for the first time NLS containing curcumin and capsaicin, and CLN containing quercetin in melanoma were tested.
id UFN-1_d4c73939274eee521079411e78f0ecaf
oai_identifier_str oai:tede.universidadefranciscana.edu.br:UFN-BDTD/1197
network_acronym_str UFN-1
network_name_str Repositório Institucional Universidade Franciscana
repository_id_str http://www.tede.universidadefranciscana.edu.br:8080/oai/request
spelling Rech , Virginia CieloKrause, Luciana FontanariVaucher , Rodrigo de AlmeidaSchuck, Patrícia FernandaVizzotto, Bruno Stefanelloda Silva, William LeonardoPohl, Ariane Ribas2023-09-06T12:26:13Z2023-05-19Pohl, Ariane Ribas. ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA. 2023. 95f. Tese( Programa de Pós-Graduação em Nanociências) - Universidade Franciscana, Santa Maria, RS.http://www.tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/1197Melanoma is the most aggressive form of skin cancer, being a highly malignant neoplasm that affects melanocytes, representing less than 5% of all cases of skin cancer, however, it causes the vast majority of deaths, reaching 80%. Overall, historically survival has been low for patients with metastatic disease and response to conventional chemotherapy has been infrequent. Due to the large number of people affected, the severity and mortality of this disease, innovative methods such as nanostructures with plant compounds may become an alternative for the treatment of cancer. Among the bioactives, quercetin and curcumin stand out, with high antioxidant and anti inflammatory power, and capsaicin, which favors the uptake of curcumin after oral ingestion. However, these natural actives have low aqueous solubility, a characteristic that makes it difficult to use them in clinical trials, and low oral bioavailability, indicating a low use of bioactives. To overcome these problems, incorporating bioactives into solid lipid nanoparticles (NLS) or nanostructured lipid composites (CLN) may allow for more efficient delivery. In this context, the objective of this study is to evaluate the effect of both, the solid lipid nanoparticle containing curcumin and capsaicin (NCC), and the nanostructured lipid carrier containing quercetin (NQ) in B16-F10 melanoma cells, in in vitro and in vitro assays. alive. The cytotoxic potentials of the nanoformulations were determined by the MTT, LDH, Neutral Red, Crystal Violet, Picogreen and hemolysis tests. All concentrations of NCC and NQ reduced melanoma cell viability by the MTT, Neutral Red, and Crystal Violet test. There was greater binding to DNA in the NCC group in the Picogreen test, showing DNA extravasation from the intracellular to the extracellular environment visualized by the double-stranded intercalator. There was a dose-dependent increase in cell death for both nanostructures in the LDH test. There was a reduction in DCFH oxidation, an indication that the antioxidant power of NCC and NQ reduced reactive oxygen species in these groups when compared to the control group. The nanoformulations did not cause hemolysis. Curcumin exhibited concentration-dependent anticoagulant activity, and the NBC and NQ groups did not affect the extrinsic coagulation cascade. For NCC and NBQ they were higher than the accepted range, showing that the anticoagulant action of curcumin in prolonging the clotting time may be due to the hydrophobic groups of its structure. In in vivo tests, treatments with NCC and NQ nanostructures significantly decreased the tumor growth rate over the 21 days of the experiment, and tumor volume was significantly inhibited by approximately 76% (0.23 mm3) and 68 % (0.3 mm3) after treatment with NCC and NQ, respectively, and tumor weight was significantly inhibited from 58% (0.71 g) and 32% (1.15 g) in NCC and NQ groups, respectively, when compared to the melanoma group (1.68 g). In the cytokine test, there was a reduction in IL-17 values in the NQ and NCC groups compared to the melanoma group, indicating the possibility of decreased tumor growth, and a decrease in IL-6 values in the group treated with NQ and NCC, decreasing thus the proliferation of tumor cells. For TNF-α, there was a reduction in the melanoma group and an increase in the NQ and NCC groups, suggesting induction of apoptosis and necrosis of tumor cells. The reduction in IL-10 values corroborates the histology results that did not find signs of metastasis in the lung. Reduction in IL-2 in the NQ and NCC groups, indicating a reduction in the proliferation of cancer cells. The results obtained in the hemogram corroborate what was found in the histology, and in the histology test, where there was no metastasis to the lung. These previous results demonstrate the ability of NCC and NQ to reduce B16-F10 melanoma cells. This thesis is original and innovative, because for the first time NLS containing curcumin and capsaicin, and CLN containing quercetin in melanoma were tested.Melanoma is the most aggressive form of skin cancer, being a highly malignant neoplasm that affects melanocytes, representing less than 5% of all cases of skin cancer, however, it causes the vast majority of deaths, reaching 80%. Overall, historically survival has been low for patients with metastatic disease and response to conventional chemotherapy has been infrequent. Due to the large number of people affected, the severity and mortality of this disease, innovative methods such as nanostructures with plant compounds may become an alternative for the treatment of cancer. Among the bioactives, quercetin and curcumin stand out, with high antioxidant and anti inflammatory power, and capsaicin, which favors the uptake of curcumin after oral ingestion. However, these natural actives have low aqueous solubility, a characteristic that makes it difficult to use them in clinical trials, and low oral bioavailability, indicating a low use of bioactives. To overcome these problems, incorporating bioactives into solid lipid nanoparticles (NLS) or nanostructured lipid composites (CLN) may allow for more efficient delivery. In this context, the objective of this study is to evaluate the effect of both, the solid lipid nanoparticle containing curcumin and capsaicin (NCC), and the nanostructured lipid carrier containing quercetin (NQ) in B16-F10 melanoma cells, in in vitro and in vitro assays. alive. The cytotoxic potentials of the nanoformulations were determined by the MTT, LDH, Neutral Red, Crystal Violet, Picogreen and hemolysis tests. All concentrations of NCC and NQ reduced melanoma cell viability by the MTT, Neutral Red, and Crystal Violet test. There was greater binding to DNA in the NCC group in the Picogreen test, showing DNA extravasation from the intracellular to the extracellular environment visualized by the double-stranded intercalator. There was a dose-dependent increase in cell death for both nanostructures in the LDH test. There was a reduction in DCFH oxidation, an indication that the antioxidant power of NCC and NQ reduced reactive oxygen species in these groups when compared to the control group. The nanoformulations did not cause hemolysis. Curcumin exhibited concentration-dependent anticoagulant activity, and the NBC and NQ groups did not affect the extrinsic coagulation cascade. For NCC and NBQ they were higher than the accepted range, showing that the anticoagulant action of curcumin in prolonging the clotting time may be due to the hydrophobic groups of its structure. In in vivo tests, treatments with NCC and NQ nanostructures significantly decreased the tumor growth rate over the 21 days of the experiment, and tumor volume was significantly inhibited by approximately 76% (0.23 mm3) and 68 % (0.3 mm3) after treatment with NCC and NQ, respectively, and tumor weight was significantly inhibited from 58% (0.71 g) and 32% (1.15 g) in NCC and NQ groups, respectively, when compared to the melanoma group (1.68 g). In the cytokine test, there was a reduction in IL-17 values in the NQ and NCC groups compared to the melanoma group, indicating the possibility of decreased tumor growth, and a decrease in IL-6 values in the group treated with NQ and NCC, decreasing thus the proliferation of tumor cells. For TNF-α, there was a reduction in the melanoma group and an increase in the NQ and NCC groups, suggesting induction of apoptosis and necrosis of tumor cells. The reduction in IL-10 values corroborates the histology results that did not find signs of metastasis in the lung. Reduction in IL-2 in the NQ and NCC groups, indicating a reduction in the proliferation of cancer cells. The results obtained in the hemogram corroborate what was found in the histology, and in the histology test, where there was no metastasis to the lung. These previous results demonstrate the ability of NCC and NQ to reduce B16-F10 melanoma cells. This thesis is original and innovative, because for the first time NLS containing curcumin and capsaicin, and CLN containing quercetin in melanoma were tested.Submitted by Clarice Rosa Machado (clarice.machado@ufn.edu.br) on 2023-09-06T12:26:13Z No. of bitstreams: 2 Tese_ArianeRibasPohl_SemAssinaturas.pdf: 2691641 bytes, checksum: 2b9416e6f15b64811d138762072b16a3 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)Made available in DSpace on 2023-09-06T12:26:13Z (GMT). No. of bitstreams: 2 Tese_ArianeRibasPohl_SemAssinaturas.pdf: 2691641 bytes, checksum: 2b9416e6f15b64811d138762072b16a3 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2023-05-19application/pdfhttp://www.tede.universidadefranciscana.edu.br:8080/retrieve/10865/Tese_ArianeRibasPohl_SemAssinaturas.pdf.jpgporUniversidade FranciscanaPrograma de Pós-Graduação em NanociênciasUFNBrasilBiociências e Nanomateriaishttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessNanotecnologia, viabilidade celular, curcumina, quercetina, câncerNanotechnology, cell viability, curcumin, quercetin, cancer.InterdisciplinarESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMAinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisreponame:Repositório Institucional Universidade Franciscanainstname:Universidade Franciscana (UFN)instacron:UFNTHUMBNAILTese_ArianeRibasPohl_SemAssinaturas.pdf.jpgTese_ArianeRibasPohl_SemAssinaturas.pdf.jpgimage/jpeg3505http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/7/Tese_ArianeRibasPohl_SemAssinaturas.pdf.jpg21f2c33d0e05fa2a327450c051f11a23MD57TEXTTese_ArianeRibasPohl_SemAssinaturas.pdf.txtTese_ArianeRibasPohl_SemAssinaturas.pdf.txttext/plain186902http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/6/Tese_ArianeRibasPohl_SemAssinaturas.pdf.txt001b70bab372a3b1b1d7d775e82ed64eMD56ORIGINALTese_ArianeRibasPohl_SemAssinaturas.pdfTese_ArianeRibasPohl_SemAssinaturas.pdfapplication/pdf2691641http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/5/Tese_ArianeRibasPohl_SemAssinaturas.pdf2b9416e6f15b64811d138762072b16a3MD55CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/2/license_url4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/3/license_textd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/4/license_rdfd41d8cd98f00b204e9800998ecf8427eMD54LICENSElicense.txtlicense.txttext/plain; charset=utf-8310http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/1/license.txt7dc66ddb96829ff34b56b1a92c851bcdMD51UFN-BDTD/11972023-09-07 01:00:08.162oai:tede.universidadefranciscana.edu.br:UFN-BDTD/1197RXN0ZSB0cmFiYWxobyBzZXLDoSBsaWNlbmNpYWRvIHNvYiBhIExpY2Vuw6dhIEF0cmlidWnDp8Ojby1Ow6NvQ29tZXJjaWFsLVNlbURlcml2YcOnw7VlcyA0LjAgSW50ZXJuYWNpb25hbCBDcmVhdGl2ZSBDb21tb25zLiBQYXJhIHZpc3VhbGl6YXIgdW1hIGPDs3BpYSBkZXN0YSBsaWNlbsOnYSwgdmlzaXRlIGh0dHA6Ly9jcmVhdGl2ZWNvbW1vbnMub3JnL2xpY2Vuc2VzL2J5LW5jLW5kLzQuMC8gb3UgbWFuZGUgdW1hIGNhcnRhIHBhcmEgQ3JlYXRpdmUgQ29tbW9ucywgUE8gQm94IDE4NjYsIE1vdW50YWluIFZpZXcsIENBIDk0MDQyLCBVU0EuCg==Repositório de Publicaçõeshttp://www.tede.universidadefranciscana.edu.br:8080/http://www.tede.universidadefranciscana.edu.br:8080/oai/requestopendoar:2023-09-07T04:00:08Repositório Institucional Universidade Franciscana - Universidade Franciscana (UFN)false
dc.title.por.fl_str_mv ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
title ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
spellingShingle ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
Pohl, Ariane Ribas
Nanotecnologia, viabilidade celular, curcumina, quercetina, câncer
Nanotechnology, cell viability, curcumin, quercetin, cancer.
Interdisciplinar
title_short ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
title_full ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
title_fullStr ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
title_full_unstemmed ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
title_sort ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA
author Pohl, Ariane Ribas
author_facet Pohl, Ariane Ribas
author_role author
dc.contributor.advisor1.fl_str_mv Rech , Virginia Cielo
dc.contributor.advisor-co1.fl_str_mv Krause, Luciana Fontanari
dc.contributor.referee1.fl_str_mv Vaucher , Rodrigo de Almeida
dc.contributor.referee2.fl_str_mv Schuck, Patrícia Fernanda
dc.contributor.referee3.fl_str_mv Vizzotto, Bruno Stefanello
dc.contributor.referee5.fl_str_mv da Silva, William Leonardo
dc.contributor.author.fl_str_mv Pohl, Ariane Ribas
contributor_str_mv Rech , Virginia Cielo
Krause, Luciana Fontanari
Vaucher , Rodrigo de Almeida
Schuck, Patrícia Fernanda
Vizzotto, Bruno Stefanello
da Silva, William Leonardo
dc.subject.por.fl_str_mv Nanotecnologia, viabilidade celular, curcumina, quercetina, câncer
topic Nanotecnologia, viabilidade celular, curcumina, quercetina, câncer
Nanotechnology, cell viability, curcumin, quercetin, cancer.
Interdisciplinar
dc.subject.eng.fl_str_mv Nanotechnology, cell viability, curcumin, quercetin, cancer.
dc.subject.cnpq.fl_str_mv Interdisciplinar
description Melanoma is the most aggressive form of skin cancer, being a highly malignant neoplasm that affects melanocytes, representing less than 5% of all cases of skin cancer, however, it causes the vast majority of deaths, reaching 80%. Overall, historically survival has been low for patients with metastatic disease and response to conventional chemotherapy has been infrequent. Due to the large number of people affected, the severity and mortality of this disease, innovative methods such as nanostructures with plant compounds may become an alternative for the treatment of cancer. Among the bioactives, quercetin and curcumin stand out, with high antioxidant and anti inflammatory power, and capsaicin, which favors the uptake of curcumin after oral ingestion. However, these natural actives have low aqueous solubility, a characteristic that makes it difficult to use them in clinical trials, and low oral bioavailability, indicating a low use of bioactives. To overcome these problems, incorporating bioactives into solid lipid nanoparticles (NLS) or nanostructured lipid composites (CLN) may allow for more efficient delivery. In this context, the objective of this study is to evaluate the effect of both, the solid lipid nanoparticle containing curcumin and capsaicin (NCC), and the nanostructured lipid carrier containing quercetin (NQ) in B16-F10 melanoma cells, in in vitro and in vitro assays. alive. The cytotoxic potentials of the nanoformulations were determined by the MTT, LDH, Neutral Red, Crystal Violet, Picogreen and hemolysis tests. All concentrations of NCC and NQ reduced melanoma cell viability by the MTT, Neutral Red, and Crystal Violet test. There was greater binding to DNA in the NCC group in the Picogreen test, showing DNA extravasation from the intracellular to the extracellular environment visualized by the double-stranded intercalator. There was a dose-dependent increase in cell death for both nanostructures in the LDH test. There was a reduction in DCFH oxidation, an indication that the antioxidant power of NCC and NQ reduced reactive oxygen species in these groups when compared to the control group. The nanoformulations did not cause hemolysis. Curcumin exhibited concentration-dependent anticoagulant activity, and the NBC and NQ groups did not affect the extrinsic coagulation cascade. For NCC and NBQ they were higher than the accepted range, showing that the anticoagulant action of curcumin in prolonging the clotting time may be due to the hydrophobic groups of its structure. In in vivo tests, treatments with NCC and NQ nanostructures significantly decreased the tumor growth rate over the 21 days of the experiment, and tumor volume was significantly inhibited by approximately 76% (0.23 mm3) and 68 % (0.3 mm3) after treatment with NCC and NQ, respectively, and tumor weight was significantly inhibited from 58% (0.71 g) and 32% (1.15 g) in NCC and NQ groups, respectively, when compared to the melanoma group (1.68 g). In the cytokine test, there was a reduction in IL-17 values in the NQ and NCC groups compared to the melanoma group, indicating the possibility of decreased tumor growth, and a decrease in IL-6 values in the group treated with NQ and NCC, decreasing thus the proliferation of tumor cells. For TNF-α, there was a reduction in the melanoma group and an increase in the NQ and NCC groups, suggesting induction of apoptosis and necrosis of tumor cells. The reduction in IL-10 values corroborates the histology results that did not find signs of metastasis in the lung. Reduction in IL-2 in the NQ and NCC groups, indicating a reduction in the proliferation of cancer cells. The results obtained in the hemogram corroborate what was found in the histology, and in the histology test, where there was no metastasis to the lung. These previous results demonstrate the ability of NCC and NQ to reduce B16-F10 melanoma cells. This thesis is original and innovative, because for the first time NLS containing curcumin and capsaicin, and CLN containing quercetin in melanoma were tested.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-09-06T12:26:13Z
dc.date.issued.fl_str_mv 2023-05-19
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Pohl, Ariane Ribas. ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA. 2023. 95f. Tese( Programa de Pós-Graduação em Nanociências) - Universidade Franciscana, Santa Maria, RS.
dc.identifier.uri.fl_str_mv http://www.tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/1197
identifier_str_mv Pohl, Ariane Ribas. ESTUDO COMPARATIVO ENTRE NANOPARTÍCULAS LIPÍDICAS SÓLIDAS COM CURCUMINA E CAPSAICINA, E CARREADOR LIPÍDICO NANOESTRUTURADO COM QUERCETINA NO TRATAMENTO DO MELANOMA. 2023. 95f. Tese( Programa de Pós-Graduação em Nanociências) - Universidade Franciscana, Santa Maria, RS.
url http://www.tede.universidadefranciscana.edu.br:8080/handle/UFN-BDTD/1197
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Franciscana
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Nanociências
dc.publisher.initials.fl_str_mv UFN
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Biociências e Nanomateriais
publisher.none.fl_str_mv Universidade Franciscana
dc.source.none.fl_str_mv reponame:Repositório Institucional Universidade Franciscana
instname:Universidade Franciscana (UFN)
instacron:UFN
instname_str Universidade Franciscana (UFN)
instacron_str UFN
institution UFN
reponame_str Repositório Institucional Universidade Franciscana
collection Repositório Institucional Universidade Franciscana
bitstream.url.fl_str_mv http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/7/Tese_ArianeRibasPohl_SemAssinaturas.pdf.jpg
http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/6/Tese_ArianeRibasPohl_SemAssinaturas.pdf.txt
http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/5/Tese_ArianeRibasPohl_SemAssinaturas.pdf
http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/2/license_url
http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/3/license_text
http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/4/license_rdf
http://tede.universidadefranciscana.edu.br:8080/bitstream/UFN-BDTD/1197/1/license.txt
bitstream.checksum.fl_str_mv 21f2c33d0e05fa2a327450c051f11a23
001b70bab372a3b1b1d7d775e82ed64e
2b9416e6f15b64811d138762072b16a3
4afdbb8c545fd630ea7db775da747b2f
d41d8cd98f00b204e9800998ecf8427e
d41d8cd98f00b204e9800998ecf8427e
7dc66ddb96829ff34b56b1a92c851bcd
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional Universidade Franciscana - Universidade Franciscana (UFN)
repository.mail.fl_str_mv
_version_ 1809269407893946368